Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 6
2005 4
2006 2
2007 5
2008 7
2009 9
2010 12
2011 10
2012 11
2013 13
2014 16
2015 15
2016 11
2017 14
2018 21
2019 21
2020 17
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D. Weerts ZZRM, et al. Among authors: frijlink hw. Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27. Gastroenterology. 2020. PMID: 31470006 Clinical Trial.
Hagedoorn P, Bawary W, Frijlink HW, Grasmeijer F. Hagedoorn P, et al. J Allergy Clin Immunol Pract. 2020 Mar;8(3):1166-1167. doi: 10.1016/j.jaip.2019.11.023. J Allergy Clin Immunol Pract. 2020. PMID: 32147136 No abstract available.
Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.
Pleguezuelos O, Dille J, de Groen S, Oftung F, Niesters HGM, Islam MA, Næss LM, Hungnes O, Aldarij N, Idema DL, Perez AF, James E, Frijlink HW, Stoloff G, Groeneveld P, Hak E. Pleguezuelos O, et al. Among authors: frijlink hw. Ann Intern Med. 2020 Apr 7;172(7):453-462. doi: 10.7326/M19-0735. Epub 2020 Mar 10. Ann Intern Med. 2020. PMID: 32150750 Clinical Trial.
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.
van Doorn E, Liu H, Ben-Yedidia T, Hassin S, Visontai I, Norley S, Frijlink HW, Hak E. van Doorn E, et al. Among authors: frijlink hw. Medicine (Baltimore). 2017 Mar;96(11):e6339. doi: 10.1097/MD.0000000000006339. Medicine (Baltimore). 2017. PMID: 28296763 Free PMC article. Clinical Trial.
Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
Murugappan S, Patil HP, Kanojia G, ter Veer W, Meijerhof T, Frijlink HW, Huckriede A, Hinrichs WL. Murugappan S, et al. Among authors: frijlink hw. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):716-25. doi: 10.1016/j.ejpb.2013.07.018. Epub 2013 Aug 8. Eur J Pharm Biopharm. 2013. PMID: 23933147
Needle-free influenza vaccination.
Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A. Amorij JP, et al. Among authors: frijlink hw. Lancet Infect Dis. 2010 Oct;10(10):699-711. doi: 10.1016/S1473-3099(10)70157-2. Lancet Infect Dis. 2010. PMID: 20883966 Review.
Nasal gene expression changes with inhaled corticosteroid treatment in asthma.
Boudewijn IM, Lan A, Faiz A, Cox CA, Brouwer S, Schokker S, Vroegop SJ, Nawijn MC, Woodruff PG, Christenson SA, Hagedoorn P, Frijlink HW, Choy DF, Brouwer U, Wisman M, Postma DS, Fingleton J, Beasley R, van den Berge M, Guryev V. Boudewijn IM, et al. Among authors: frijlink hw. Allergy. 2020 Jan;75(1):191-194. doi: 10.1111/all.13952. Epub 2019 Jul 15. Allergy. 2020. PMID: 31230369 No abstract available.
176 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page